Clinical trial · Observational
Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer
Clinicopathological Characteristics and Prognosis Analysis of Stage IB Non-small Cell Lung Cancer：A Retrospective Real World Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of this observation study is to learn about clinicopathological characteristics and prognostic factors of stage IB NSCLC. The main question it aims to answer is wheather there is relationship between newly proposed clinicopathological features and the prognosis of stage IB NSCLC .The postoperative pathological and follow-up information of participants will be used for subsequent analysis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Stage IB Non-Small Cell Lung Carcinoma | Lung Non-Small Cell Carcinoma | CURATED_BROADER | 0.78 |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- ZS-IB-NSCLC
- description
- A total of 971 NSCLC patients with pathological stage IB resected by surgery (R0) from January 2016 to December 2020 at Zhongshan Hospital of Fudan University
Primary outcomes (1)
- measure
- RFS
- timeFrame
- 5 years
- description
- recurrence-free survival
Secondary outcomes (1)
- measure
- OS
- timeFrame
- 5 years
- description
- overall survival
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * It was confirmed by histopathology as primary non-small cell lung cancer, and the pathological type was LUSC or LUAD; * According to the 8th edition of TNM clinical staging standards, it is determined as IB stage * No treatment was performed for the primary lesion of lung cancer before surgery; * No history of other malignant tumors before surgery; * Detailed clinical and pathological information, complete survival data, and no missing follow-up data. Exclusion Criteria: * The postoperative histopathological types include non-scale and non adenocarcinoma, such as lung adenosquamous cell carcinoma, large cell lung cancer, or lung sarcomatoid carcinoma; * Multiple lesion staging surgery; * History of merging with other malignant tumors * Having preoperative treatment; * Missing follow-up information.
References
Publications (0)
Data not yet available